FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

30251311000001102: Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Sep 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1953151000001110 Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1953161000001113 Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
94034301000001119 Synagis 50mg/0.5ml solution for injection vials (AbbVie Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
94034401000001110 Synagis 50mg/0.5ml solution for injection vials (AbbVie Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Is a Palivizumab 50mg/0.5ml solution for injection vials true Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Has active ingredient Palivizumab true Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Has specific active ingredient Palivizumab true Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Is a Synagis true Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Has manufactured dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) 1 vial Has AMP True Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start